journal club presentation for chemical pathology group of doctors and scientists. Presentation to explain the clinical reasoning behind this and whether we should consider looking into adding 11-oxygenated androgens to our test panel.
journal club presentation for chemical pathology group of doctors and scientists. Presentation to explain the clinical reasoning behind this and whether we should consider looking into adding 11-oxygenated androgens to our test panel.
Created using ChatSlide
This study explores the significance of measuring 11-oxygenated androgens in women with Polycystic Ovary Syndrome (PCOS). It highlights findings from a secondary analysis of NIH-funded trials involving 373 women, revealing the limitations of total testosterone as a diagnostic marker. The potential benefits of incorporating these tests into laboratory practice are discussed, particularly for assessing hyperandrogenism and monitoring treatment, while also addressing analytical challenges such...